-
Signature
-
/s/ Robin Schulman, Attorney-in-Fact for Brian G. Robins
-
Stock symbol
-
GTLB
-
Transactions as of
-
Oct 1, 2024
-
Transactions value $
-
-$830,406
-
Form type
-
4
-
Date filed
-
10/3/2024, 04:23 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
GTLB |
Class A Common Stock |
Conversion of derivative security |
$0 |
+16.7K |
+6.86% |
$0.00 |
259K |
Oct 1, 2024 |
Direct |
F1 |
transaction |
GTLB |
Class A Common Stock |
Sale |
-$760K |
-15.3K |
-5.88% |
$49.76 |
244K |
Oct 1, 2024 |
Direct |
F2, F3 |
transaction |
GTLB |
Class A Common Stock |
Sale |
-$70.8K |
-1.4K |
-0.57% |
$50.55 |
243K |
Oct 1, 2024 |
Direct |
F2, F4, F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
GTLB |
Stock Option (Right to buy Class B Common Stock) |
Options Exercise |
$0 |
-16.7K |
-2.38% |
$0.00 |
683K |
Oct 1, 2024 |
Class B Common Stock |
16.7K |
$9.99 |
Direct |
F2, F6 |
transaction |
GTLB |
Class B Common Stock |
Options Exercise |
|
+16.7K |
|
|
16.7K |
Oct 1, 2024 |
Class A Common Stock |
16.7K |
$9.99 |
Direct |
F1, F2 |
transaction |
GTLB |
Class B Common Stock |
Conversion of derivative security |
|
-16.7K |
-100% |
|
0 |
Oct 1, 2024 |
Class A Common Stock |
16.7K |
|
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: